All News

How one cancer survivor attempts to cope with the reality of having chemo for the rest of her life.

In a recent phase 2 study, nearly half of patients who had resectable stage 3B/C BRAF V600-mutant melanoma achieved pathologic complete response (pCR) – meaning that no active cancer cells are present – with neoadjuvant combination therapy consisting of Tafinlar (dabrafenib) and Mekinist (trametinib).

Genomic testing is often expensive and inaccessible to those who can't afford the costs, but companies are working diligently to provide people with alternatives.

Blogging for CURE helped me find my voice and process my breast cancer experience.

From fatigue to chemo brain, Curetoday.com and CURE Magazine offer a variety of resources for people dealing with these effects.

Brian d'Arcy James of 13 Reasons Why, Spotlight, and Hamilton is set to take on the 2017 Bank of America Chicago Marathon and raise money to support cancer patients and their loved ones served by the Cancer Support Community.

In early 2015, Zika outbreaks caused widespread panic in many parts of North and South America. However, now researchers are exploring the possibility of putting the virus to good use: fighting glioblastoma multiforme (GBM), the most deadly type of brain cancer.

How a fake Buddha quote changed my life.

At one time, the word “cancer” was only whispered and never spoken out loud. Times change, but sometimes it’s hard to let those you work with know that you have/had cancer.

Jevtana (cabazitaxel) was granted approval by the Food and Drug Administration (FDA) for the treatment of men with metastatic castration-resistant prostate cancer who previously received a docetaxel-containing regimen.

People used to think that palliative care and hospice were one in the same. However, now it has a separate category of its own.

Martha Carlson talks about what it's like to join a group of active advocates for stage 4 breast cancer

An optimistic attitude is beneficial to achieving good health. Those affected by cancer need to learn to tap into the valuable resource of positive self-talk. Here's how:

Chemo brain affects each of us in different ways. Using our brains to negotiate a relationship with it is, ironically, the best way to forge ahead without despairing.

An injured cancer survivor reluctantly but gratefully copes with neuropathy, osteopenia and stiff-joint cancer side effects after recently breaking her foot and getting surgery.

The Food and Drug Administration approved the first ever biosimilar to treat a variety of cancers.

David S. Siegel, M.D., Ph.D., chief of the division of Multiple Myeloma at the John Theurer Cancer Center, attributes some of the progress in myeloma treatment to patients and how they advocate for themselves.

Stroke survivors were diagnosed with cancer at almost double the rate of incidence in the general population, one study showed.

Aliqopa (copanlisib) was granted FDA approval for the treatment of patients with relapsed follicular lymphoma who have received at least two least prior systemic therapies.

A former Disney cast member and cancer survivor discovers a new meaning to these beloved lyrics.

A breast cancer and melanoma survivor offers ideas to help newly diagnosed cancer patients cope and get through their cancer.

One breast cancer survivor learns to finally accept breast cancer awareness month.

Women with ovarian or breast cancer often don’t receive the genetic testing they need in order to devise the best treatment plans, a new study says.

It's hard to watch someone choose to end or forgo conventional treatment without succumbing to the urge to educate. But education isn't always what patients need.

Some of us fumble more than others. I was one of those emotional wrecks, wearing my emotions on my sleeve.

With summer over, two-time cancer survivor and clutter-clearing author shares time management help with a cancer-enhanced awareness that her time is her life.

The risk of relapse dropped 53 percent when trametinib and dabrafenib were used after therapy.

Research announced at the Madrid conference could radically change treatment for lung cancer, melanoma and kidney cancer

Patients, survivors and their caregivers may not be getting the whole picture as presented by the lay media.

Extended use of aromatase inhibitors (AIs) in early breast cancer is associated with an increased risk of cardiovascular events and bone fractures, according to results from a study published in the Journal of the National Cancer Institute.